MeSH tree: G05.370
Michigan's Oncology Sequencing Program, or MiOncoSeq, was the first of its kind in the nation to sequence patient tumors. Launched in 2010, the program analyzes DNA and RNA from normal tissue and tumors to identify alterations ...
3 hours ago
0
0
A new study finds that when p53, one of the most important cancer-protecting genes, stops working, cells produce too much RNA and consume excessive amounts of the building blocks needed to copy their DNA. This shortage disrupts ...
Sep 7, 2026
0
14
A subset of cancers, known as microsatellite instability (MSI) and deficient DNA mismatch repair (dMMR) cancers, are more visible to the immune system than others. Because their DNA repair systems are defective, these tumors ...
Jul 16, 2026
0
7
How diseases develop and how the body ages can differ between females and males, but the biological reasons for these differences are not fully understood. Researchers are studying the role of sex chromosomes to better understand ...
Jun 10, 2026
0
5
Chromosomal instability is a common feature in many solid tumors and is associated with greater aggressiveness. For years, its main contribution to cancer was thought to be driving the evolution of tumor genomes, causing ...
Jun 6, 2026
0
13
Researchers at Trinity have found that a largely overlooked form of cancer evolution, which drives aggressive disease and poor patient outcomes, is far more widespread than previously thought. Comparing chromosome patterns ...
Jun 2, 2026
0
5
A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key features that may help predict which types of rare cancers are likely to respond to immunotherapy.
May 20, 2026
0
3
B-cell acute lymphoblastic leukemia is the most common form of childhood cancer. In this type of cancer, which affects blood cells, one of the most common abnormalities is the presence of cells with an excess of chromosomes ...
Apr 8, 2026
0
7
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help identify and characterize asymptomatic people with Lynch Syndrome (LS) who are more susceptible to ...
Apr 7, 2026
0
10
New research has uncovered new insights into why the most aggressive esophageal cancers are so difficult to treat and how the body's own defense systems are helping them to thrive. The study, led by Professor Eileen Parkes ...
Mar 16, 2026
0
10
